StockDriftsStockDriftsSK Biopharm (326030) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for SK Biopharm is dated 2024-03-15; the most recent is 2026-03-30.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-09-15 | BUY | Market Buy | 유창호 Yoo Chang-ho | Head of Strategy Division | 500 | ₩78,300 | +0.0% | ₩40M ($27K) |
| 2026-09-15 | BUY | Market Buy | 이동훈 Kim Ki-won | president | 1.0K | ₩78,300 | +0.0% | ₩79M ($55K) |
| 2026-08-31 | BUY | Market Buy | 유창호 Yoo Chang-ho | Head of Strategy Division | 500 | ₩87,300 | +1.9% | ₩44M ($31K) |
| 2026-08-31 | BUY | Market Buy | 이동훈 Kim Ki-won | president | 2.0K | ₩87,300 | +1.9% | ₩182M ($126K) |
| 2026-03-30 | SELL | 시간외매매 | SK | - | -10.9M | ₩97,400 | -4.8% | ₩1.1T ($738.4M) |
| 2025-01-01 | BUY | 신규선임 | 조형래 Cho Hyung-rae | Head of Communication Division | 4.5K | ₩108,600 | +7.9% | ₩489M ($339K) |
| 2024-03-15 | SELL | 증여 | 정지영 Jeong Ji-young | Head of Finance Division | -6.3K | ₩93,900 | -24.8% | ₩592M ($411K) |
| 2024-03-15 | BUY | 기타 | 정지영 Jeong Ji-young | Head of Finance Division | 6.3K | ₩93,900 | +24.8% | ₩592M ($411K) |
Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.